DNA Patent Suit Settled For $3.35M
California-based Cepheid agreed to pay the sum in a one-time payment to rival Idaho Technology Inc. The settlement also included a cross-licensing agreement between the parties.
“ITI is pleased to have reached a settlement with Cepheid that allows both companies to continue to offer innovative instrumentation, chemistry, and data analysis solutions for their customers,” said Randy Rasmussen, Idaho Technology’s chief operating officer.
Cepheid’s executive officer, John Bishop, concurred....
To view the full article, register now.